CellGenix® Preclinical rh IL-18
- Recombinant Human Interleukin-18.
- Optimal use for the proliferation of natural killer (NK) cells and differentiation of naive T cells towards Th1 effector cells.
- ADCF Level 2.
- High purity to ensure the safety of your process.
- Endotoxin Level ≤ 25 EU/mg
Quality Grade
- Item No.:
- 1429-050
Added to Shopping Cart
Choose your CellGenix® Growth Factors and Cytokines
CellGenix® Recombinant Human Interleukin-18 (IL-18) is an animal-derived component-free product. It is produced in a dedicated animal-free facility.
IL-18 is used in the cell and gene therapy space for the ex vivo activation and expansion of T cells, including for CAR-T cell, NK cell, and TCR therapies.
Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.
Please access the Certificate of Analysis on the My Sartorius Portal.
Expiry: 3 years from date of shipping
Applications
-
Application Area
-
Cell & gene therapy
- Immunology
-
Cell & gene therapy
-
Cell Type
-
NK Cells
- T Cells
-
NK Cells
-
Intended UsePreclinical ex vivo use
Biological Information
-
Activity≥ 2 × 10⁶ U/mg
Compliance Information
-
OriginAnimal-Component Free
-
Quality GradePreclinical
Physicochemical Information
-
Endotoxin≤ 25 EU/mg
-
Expression SystemE. coli
Product Information
-
BrandCellGenix®
-
Package TypeVial
-
Size50 µg
Sterility/Purity
-
Delivery ConditionSterile
-
Purity≥ 95%
Weight
-
Molecular Weight (kDa)18.2 kDa